| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |